StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech, healthcare · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | ABBV AbbVie | $212.93 | -2.20% | $384.7B | 105.8 | 6.1 | +9.5% | 72.0% | 61 |
| 1 | GILD Gilead Sciences | $131.10 | -2.48% | $163.2B | 17.7 | 5.5 | +3.5% | 79.3% | 61 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $329.13 |
| -2.27% |
| $178.3B |
| 22.9 |
| 4.8 |
| +9.1% |
| 74.0% |
| 52 |
| 3 | REGN Regeneron | $600.66 | -2.30% | $62.7B | 14.2 | 4.2 | +5.9% | 85.7% | 47 |
| 4 | VRTX Vertex Pharma | $438.40 | -2.04% | $113.6B | 26.2 | 9.3 | +10.1% | 86.2% | 47 |
| 5 | ALNY Alnylam Pharmaceuticals | $295.63 | -2.10% | $40.4B | 70.0 | 9.4 | +82.6% | 80.8% | 46 |
| 6 | 950160.KQ 950160.KQ | — | — | — | — | — | — | — | — |
| 7 | 950220.KQ 950220.KQ | — | — | — | — | — | — | — | — |
| 8 | 950200.KQ 950200.KQ | — | — | — | — | — | — | — | — |
| 9 | RVMD RVMD | $163.68 | +3.94% | $34.8B | — | 3007.1 | — | — | — |